Abstract
During JADPRO Live 2024, Vincent Harris, PharmD, BCOP, discussed investigational therapeutic agents in the drug development pipeline. Dr. Harris highlighted new drug classes, novel mechanisms of action, and safety profiles that advanced practitioners should be aware of.
